Lv3
320 积分 2025-12-31 加入
The evolving landscape of RAS-targeted therapies
3天前
已完结
The Metabolic Landscape of RAS-Driven Cancers from biology to therapy
3天前
已完结
Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNA
4天前
已完结
A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment
4天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
13天前
已完结
Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers
1个月前
已完结
Design, synthesis and biological activity evaluation of novel 4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl) oxy) pyridine-2-yl) amino derivatives as potent transforming growth factor-β (TGF-β) type I receptor inhibitors
1个月前
已完结
Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors
1个月前
已完结
Discovery of novel pyridine skeleton derivatives as potent CLK2/3 inhibitors
1个月前
已完结
Synthesis and biological evaluation of 4-(pyridine-4-oxy)-3-(tetrahydro-2H-pyran-4-yl)-pyrazole derivatives as novel, potent of ALK5 receptor inhibitors
1个月前
已完结
皖公网安备34019202002308
